Department of Ophthalmology, The Penn State Hershey Eye Center, Penn State Hershey College of Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States of America.
PLoS One. 2012;7(9):e44711. doi: 10.1371/journal.pone.0044711. Epub 2012 Sep 6.
Synaptophysin, is an abundant presynaptic protein involved in synaptic vesicle recycling and neurotransmitter release. Previous work shows that its content is significantly reduced in the rat retina by streptozotocin (STZ)-diabetes. This study tested the hypothesis that STZ-diabetes alters synaptophysin protein turnover and glycosylation in the rat retina. Whole explant retinas from male Sprague-Dawley rats were used in this study. Rats were made diabetic by a single intraperitoneal STZ injection (65 mg/kg body weight in 10 mM sodium citrate, pH 4.5). mRNA translation was measured using a (35)S-methionine labeling assay followed by synaptophysin immunoprecipitation and autoradiography. A pulse-chase study was used to determine the depletion of newly synthesized synaptophysin. Depletion of total synaptophysin was determined after treatment with cycloheximide. Mannose rich N-glycosylated synaptophysin was detected by treating retinal lysates with endoglycosidase H followed by immunoblot analysis. Synaptophysin mRNA translation was significantly increased after 1 month (p<0.001) and 2 months (p<0.05) of STZ-diabetes, compared to age-matched controls. Newly synthesized synaptophysin degradation was significantly accelerated in the retina after 1 and 2 months of diabetes compared to controls (p<0.05). Mannose rich glycosylated synaptophysin was significantly increased after 1 month of STZ-diabetes compared to controls (p<0.05).These data suggest that diabetes increases mRNA translation of synaptophysin in the retina, resulting in an accumulation of mannose rich glycosylated synaptophysin, a transient post-translational state of the protein. This diabetes-induced irregularity in post-translational processing could explain the accelerated degradation of retinal synaptophysin in diabetes.
突触素是一种丰富的突触前蛋白,参与突触囊泡的再循环和神经递质的释放。先前的研究表明,链脲佐菌素(STZ)-糖尿病可使大鼠视网膜中的突触素含量显著降低。本研究旨在验证 STZ-糖尿病是否改变大鼠视网膜中突触素蛋白的周转率和糖基化。本研究使用雄性 Sprague-Dawley 大鼠的全离体视网膜。大鼠通过单次腹腔注射 STZ(10mM 柠檬酸钠,pH4.5 中的 65mg/kg 体重)诱导糖尿病。使用 35S-甲硫氨酸标记测定法测量 mRNA 翻译,然后进行突触素免疫沉淀和放射自显影。使用脉冲追踪研究来确定新合成的突触素的耗竭情况。用环己酰亚胺处理后测定总突触素的耗竭。用内切糖苷酶 H 处理视网膜裂解物,然后进行免疫印迹分析,检测富含甘露糖的 N-糖基化突触素。与年龄匹配的对照组相比,STZ 糖尿病 1 个月(p<0.001)和 2 个月(p<0.05)后,突触素 mRNA 翻译明显增加。与对照组相比,糖尿病 1 个月和 2 个月后,视网膜中新合成的突触素降解明显加快(p<0.05)。与对照组相比,STZ 糖尿病 1 个月后富含甘露糖的糖基化突触素明显增加(p<0.05)。这些数据表明,糖尿病增加了视网膜中突触素的 mRNA 翻译,导致富含甘露糖的糖基化突触素积累,这是蛋白质的一种短暂的翻译后状态。这种糖尿病诱导的翻译后加工异常可能解释了糖尿病中视网膜突触素的加速降解。